TRT Side Effects: What's Real, What's Rare, and How to Manage Them

Testosterone replacement therapy (TRT) is one of the most misunderstood medical treatments available. Online forums are packed with horror stories about heart attacks, infertility, and "roid rage" — while millions of men with clinically low testosterone continue to suffer from fatigue, depression, poor body composition, and sexual dysfunction because they're afraid to treat the underlying cause.

The truth is more nuanced. TRT does carry real risks — but most of them are manageable with proper medical oversight, routine lab monitoring, and appropriate dosing. Understanding the difference between documented common side effects and rare or overstated concerns is critical for making an informed decision about your health.

First: What Qualifies as TRT?

TRT refers to physician-prescribed testosterone therapy for men with clinically diagnosed hypogonadism — typically defined as two fasting morning total testosterone readings below 300 ng/dL, accompanied by symptoms of low T. This is distinct from anabolic steroid use, which involves supraphysiologic doses far above the normal therapeutic range. Most of the extreme side effects associated with "steroids" in popular culture come from doses 5–20x higher than what TRT prescribes.

Medically supervised TRT aims to bring testosterone levels into the normal physiologic range (400–700 ng/dL total T for most men), not to produce supraphysiologic levels. This distinction matters enormously for the side effect profile.

Side Effects That Are Real and Relatively Common

1. Polycythemia (Elevated Hematocrit and Red Blood Cell Count)

This is the most clinically significant routine side effect of TRT. Testosterone stimulates the production of erythropoietin (EPO), which in turn drives red blood cell production. Elevated hematocrit (the percentage of blood volume occupied by red blood cells) makes blood more viscous and theoretically increases the risk of blood clots, stroke, and cardiovascular events if left unmanaged.

The incidence of hematocrit elevation above 54% (the threshold of concern) is approximately 10–20% in TRT patients, making it the most common reason for dose adjustment or temporary discontinuation. However, it's entirely detectable through routine blood work — which is why standard TRT monitoring includes a complete blood count (CBC) every 3–6 months. When hematocrit rises above the threshold, the standard interventions are dose reduction, switching to a shorter-acting formulation for tighter control, or therapeutic phlebotomy (blood donation), which is simple, effective, and widely available.

2. Testicular Atrophy and Reduced Sperm Production

When exogenous testosterone enters the body, the pituitary gland detects it and reduces its secretion of LH (luteinizing hormone) and FSH (follicle-stimulating hormone). LH stimulates testicular testosterone production; FSH stimulates sperm production. When both signals decline, the testes receive less stimulation, leading to reduced size (atrophy) and reduced sperm production — azoospermia in some cases.

This is real, predictable, and largely reversible. For men who don't want to compromise fertility, the standard solution is to add human chorionic gonadotropin (hCG) to the TRT protocol. hCG mimics LH, keeps the testes stimulated, maintains testicular size, and largely preserves fertility even during TRT. For men not concerned with fertility, testicular atrophy is primarily cosmetic and reversal typically occurs within months of discontinuing TRT.

3. Acne and Oily Skin

Testosterone converts to dihydrotestosterone (DHT) via the 5-alpha reductase enzyme. DHT stimulates sebaceous glands, increasing oil production and sometimes causing acne — particularly on the back, chest, and shoulders. This affects roughly 10–15% of TRT users to a noticeable degree. Management options include topical retinoids, benzoyl peroxide wash, or in severe cases isotretinoin. Some men also benefit from switching to a lower-dose, more frequent injection schedule to minimize testosterone peaks.

4. Estrogen-Related Side Effects

Testosterone aromatizes into estradiol. In some men — particularly those with higher body fat or genetic predispositions — estradiol can rise excessively, causing water retention, mood changes, or gynecomastia (breast tissue development). This is manageable with aromatase inhibitors (AIs) like anastrozole when estradiol is confirmed elevated on labs. Note: overuse of AIs is a common error; low estradiol causes its own problems (joint pain, low libido, poor mood) and should be avoided. Proper monitoring is key.

Side Effects That Are Rare or Heavily Overstated

1. Cardiovascular Disease

This is perhaps the most feared concern — and the most nuanced. Early studies suggested TRT might increase cardiovascular risk; more recent large-scale evidence has substantially revised this picture. The TRAVERSE trial (2023), the largest randomized controlled trial of TRT ever conducted involving 5,246 men over 33 months, found no significant difference in major adverse cardiovascular events (MACE) between TRT-treated men and placebo — and TRT improved several cardiovascular risk factors including body composition and insulin sensitivity.

The current consensus from the American Urological Association and the Endocrine Society: TRT at physiologic doses in hypogonadal men does not increase cardiovascular risk and may improve it. Men with pre-existing cardiovascular disease or recent cardiac events should have a thorough risk discussion with their provider.

2. Prostate Cancer Stimulation

The historical "testosterone fuels prostate cancer" concern stemmed from 1940s observations that castration shrank prostate tumors. This was long interpreted as evidence that normal testosterone levels drive cancer growth — a conclusion that has since been largely overturned. The "saturation model" now holds that prostate androgen receptors saturate at relatively low testosterone concentrations (around 150–200 ng/dL); above this threshold, additional testosterone does not increase cancer risk.

Multiple prospective studies have found no increased rate of prostate cancer in men on TRT versus untreated controls. TRT is contraindicated in men with active, untreated prostate cancer — but for most men, it does not meaningfully increase prostate cancer risk.

3. Roid Rage and Psychiatric Episodes

The aggression associated with anabolic steroids stems primarily from supraphysiologic dosing — testosterone levels 5–20x above normal. At physiologic TRT doses, the psychological effects are generally positive: reduced depression and anxiety, improved mood, better stress resilience, and enhanced motivation. Many men on well-managed TRT report it as one of the most impactful quality-of-life improvements they've made.

4. Liver Damage

Liver toxicity is a legitimate concern with oral 17-alpha alkylated anabolic steroids (like Anadrol or Winstrol), which are metabolized first-pass through the liver. Injectable testosterone, transdermal gels, and other modern TRT delivery methods bypass first-pass liver metabolism almost entirely. Liver damage from properly prescribed TRT is extremely rare and is not a standard monitoring concern at physiologic doses.

TRT Side Effect Risk Summary

Side Effect	How Common	Severity	Prevention / Management
Elevated hematocrit	10–20%	Clinically significant if unmonitored	Routine CBC; dose adjustment or phlebotomy
Testicular atrophy	Very common	Cosmetic / fertility concern	Add hCG to protocol; reversible off TRT
Reduced sperm count	Common	Fertility concern	hCG co-administration; generally reversible
Acne / oily skin	10–15%	Mild to moderate	Topicals, dose adjustment, frequency change
Gynecomastia / water retention	5–10%	Mild in most cases	Monitor estradiol; AI if indicated
Sleep apnea worsening	Moderate in at-risk men	Moderate	Screen before TRT; CPAP if needed
Cardiovascular events	Rare (no increase vs. placebo in TRAVERSE)	High if it occurs	Manage hematocrit; baseline cardiovascular assessment
Prostate cancer	Rare / not increased vs. untreated	High if present	PSA monitoring; contraindicated with active disease
Liver damage	Very rare with injectable / transdermal	High if severe	Avoid oral 17-alkylated steroids

Sleep Apnea: An Underappreciated Risk

One side effect worth special attention: TRT can worsen or unmask obstructive sleep apnea (OSA) in susceptible men. Testosterone affects respiratory drive and upper airway musculature, and men with obesity or existing mild sleep apnea may see their OSA worsen on TRT. Symptoms to watch for include increased snoring, excessive daytime sleepiness, or morning headaches. Men with known OSA should be on CPAP therapy before or alongside starting TRT. Providers should screen for OSA risk factors at baseline.

Why Medical Supervision Makes All the Difference

The vast majority of TRT side effects are either preventable or detectable early through proper monitoring. A well-run TRT program includes:

• Baseline labs: total and free testosterone, LH, FSH, estradiol, hematocrit/CBC, PSA, lipid panel, metabolic panel
• Follow-up labs at 6–12 weeks after initiation, then every 3–6 months
• Dose titration based on lab values and symptoms — not guesswork
• Monitoring and management of hematocrit, estradiol, and PSA
• Availability of ancillary protocols (hCG for fertility preservation, AI if estradiol elevates)
• Regular symptom check-ins to optimize quality of life

Men who obtain testosterone through unmonitored channels — online without lab requirements, from friends, or from providers who don't follow up — are the ones who run into serious problems. Medically supervised TRT at physiologic doses is a safe, well-studied treatment for a real medical condition. The side effect profile, managed properly, is far more benign than the continuing toll of untreated hypogonadism on cardiovascular health, bone density, mental health, and quality of life.